Dimensional Fund Advisors Portfolio holdings
Dimensional Fund Advisors (DFA), founded in 1981 by David Booth and Rex Sinquefield and headquartered in Austin, Texas, is an investment management firm renowned for its evidence-based, low-cost approach to investing, grounded in academic research from Nobel laureates like Eugene Fama and Kenneth French. Managing hundreds of billions in assets, DFA focuses on systematic, passive strategies that tilt toward factors like small-cap, value, and profitability stocks, primarily through mutual funds and institutional portfolios rather than retail brokerage services. The firm’s philosophy eschews market timing and stock picking, instead emphasizing diversification and efficient market exposure, often requiring investors to access its funds through approved financial advisors. With a global presence and a reputation for disciplined, data-driven investing, DFA has carved a unique niche in the industry, blending academic rigor with practical application.
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
+$401M |
| 2 |
NVIDIA
NVDA
|
+$333M |
| 3 |
Costco
COST
|
+$236M |
| 4 |
Amazon
AMZN
|
+$215M |
| 5 |
Johnson & Johnson
JNJ
|
+$160M |
Top Sells
| 1 |
Broadcom
AVGO
|
+$322M |
| 2 |
Super Micro Computer
SMCI
|
+$284M |
| 3 |
JPMorgan Chase
JPM
|
+$178M |
| 4 |
WIRE
Encore Wire Corp
WIRE
|
+$160M |
| 5 |
Intel
INTC
|
+$152M |
Sector Composition
| 1 | Technology | 19.73% |
| 2 | Financials | 17.51% |
| 3 | Industrials | 12.44% |
| 4 | Consumer Discretionary | 10.71% |
| 5 | Healthcare | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Clover Health Investments
CLOV
$1.48B
| $265K | ﹤0.01% |
94,128
| – | – |
|
3127
ImmuCell
ICCC
$55.7M
| $264K | ﹤0.01% |
72,682
+6,613
| +10% | +$24K |
|
3128
WidePoint Corp
WYY
$51.8M
| $262K | ﹤0.01% |
74,041
+12,983
| +21% | +$46K |
|
3129
HireQuest
HQI
$138M
| $261K | ﹤0.01% |
18,457
-1,513
| -8% | -$21.4K |
|
3130
Fresenius Medical Care
FMS
$14.8B
| $260K | ﹤0.01% |
12,220
-319
| -3% | -$6.8K |
|
3131
Braze
BRZE
$3.48B
| $256K | ﹤0.01% |
7,921
-29,863
| -79% | -$966K |
|
|
ATYR
3132
aTyr Pharma
ATYR
$520M
| $256K | ﹤0.01% |
145,524
| – | – |
|
3133
Star Bulk Carriers
SBLK
$2.25B
| $251K | ﹤0.01% |
10,578
-391,809
| -97% | -$9.28M |
|
|
QIPT
3134
Quipt Home Medical
QIPT
$113M
| $249K | ﹤0.01% |
+85,270
| New | +$249K |
|
|
NAGE
3135
Niagen Bioscience, Inc. Common Stock
NAGE
$748M
| $248K | ﹤0.01% |
67,953
+35,842
| +112% | +$131K |
|
3136
Natural Health Trends
NHTC
$54.1M
| $247K | ﹤0.01% |
41,486
-6,679
| -14% | -$39.7K |
|
3137
DocGo
DCGO
$155M
| $243K | ﹤0.01% |
+73,259
| New | +$243K |
|
3138
Seer Inc
SEER
$114M
| $242K | ﹤0.01% |
122,711
| – | – |
|
3139
Vesta Real Estate
VTMX
$2.37B
| $242K | ﹤0.01% |
8,970
-3,961
| -31% | -$107K |
|
3140
Trevi Therapeutics
TRVI
$1.03B
| $241K | ﹤0.01% |
72,210
| – | – |
|
3141
Nortech Systems
NSYS
$25.9M
| $240K | ﹤0.01% |
20,505
+9,637
| +89% | +$113K |
|
3142
NCS Multistage Holdings
NCSM
$118M
| $240K | ﹤0.01% |
11,990
+1,469
| +14% | +$29.4K |
|
3143
Relmada Therapeutics
RLMD
$51.8M
| $238K | ﹤0.01% |
73,404
+4
| +0% | +$13 |
|
3144
Gray Media, Inc. Class A
GTN.A
$1.02B
| $235K | ﹤0.01% |
33,800
| – | – |
|
3145
Tyra Biosciences
TYRA
$630M
| $233K | ﹤0.01% |
+9,907
| New | +$233K |
|
|
PPTA
3146
Perpetua Resources
PPTA
$1.8B
| $233K | ﹤0.01% |
24,894
| – | – |
|
3147
CarParts.com
PRTS
$52.1M
| $232K | ﹤0.01% |
255,722
-593,800
| -70% | -$538K |
|
3148
Globalstar
GSAT
$4.68B
| $230K | ﹤0.01% |
12,416
| – | – |
|
3149
Soleno Therapeutics
SLNO
$3.73B
| $228K | ﹤0.01% |
+4,522
| New | +$228K |
|
3150
Fossil Group
FOSL
$159M
| $228K | ﹤0.01% |
194,764
-145,889
| -43% | -$171K |
|